| 盐酸伊立替康致迟发性腹泻作用机制及防治的研究进展 |
| |
| 引用本文： | 张晓光,张侠.盐酸伊立替康致迟发性腹泻作用机制及防治的研究进展[J].中国药物警戒,2012(9):535-538. |
| |
| 作者姓名： | 张晓光 张侠 |
| |
| 作者单位： | 北京军区总医院肿瘤科,北京100700 |
| |
| 摘 要： | 目的综述伊立替康致迟发性腹泻发生机制以及预防和治疗药物的研究进展。方法检索PUBMED和中国知网2001-2011年国内外相关文献,对伊立替康致迟发性腹泻进行分析。结果伊立替康体内代谢过程受多种代谢酶、基因、蛋白的影响,多种药物对迟发性腹泻有不用程度的治疗作用。结论了解伊立替康致迟发性腹泻的机制,可进一步提高该药的临床有效性和安全性。
|
| 关 键 词： | 伊立替康 腹泻 尿苷二磷酸葡萄糖醛酸转移酶(UGT1A1) 防治 |
Study on the Development of the Mechanism of Action, Prevention and Treatment for Irinotecan-induced Diarrhea |
| |
| ZHANG Xia.Study on the Development of the Mechanism of Action, Prevention and Treatment for Irinotecan-induced Diarrhea[J].Chinese JOurnal of Pharmacovigilance,2012(9):535-538. |
| |
| Authors: | ZHANG Xia |
| |
| Institution: | ZHANG Xiao-guang ZHANG Xia (Department of Oncology, the Military General Hospital of Beijing PLA, Beijing 100700, China) |
| |
| Abstract: | Objective To review the mechanism of irinotecan-induced type diarrhea and the prevention and therapy for it. Methods Analyze the irinotecan-induced diarrhea based on the relevance literature searched on the PUBMED and CNKI from 2001 to 2011. Results Metabolic processes of irinotecan is affected by a variety of metabolic en- zymes, genes and proteins. Many drugs have different therapeutic effects for the delayed diarrhea. Gonlusion Make an in-depth understanding of the mechanism of irinotecan-induced delayed diarrhea, which can further improve its safety and efficacy. |
| |
| Keywords: | irinotecan diarrhea UGT1A1 prevention and treatment |
| 本文献已被 CNKI 维普 等数据库收录！ |
